Loading provider…
Loading provider…
Neurological Surgery Physician in Los Angeles, CA
NPI: 1063830735Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get M.D. Frances's Phone Numberphone_androidMobile
Get M.D. Frances's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2016 - 2027
CA State Medical License

American Board of Psychiatry and Neurology
Neurology

Neurocritical Care Society
Certification of Emergency Neurological Life Support
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Neuro-Oncology
2018 - 2020
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Chief Residency • Neurology
2017 - 2018
Residency • Neurology
2015 - 2018
University of California (Irvine)
Internship • Transitional Year
2014 - 2015
Drexel University College Of Medicine
drexel.edu
Medical School
Until 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 27 | 87 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 24 | 66 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 16 | 17 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 12 | 21 |
Authors: Lisa Nachtigall, Arati Desai, Eliza Geer, Viviane Tabar, Byram Ozer, Marc Rosenblum, Jamie Tisnado, Jorg Dietrich, Andrew Lin, Sharon Wardlaw, Nazanin Majd, Tejus Bale
Journal: Acta Neuropathol
Publication Date: 2024-05-17
The abscopal effect: systematic review in patients with brain and spine metastases.
Authors: Eric Chang, Frank Attenello, Jacob Ruzevick, Gabriel Zada, Jason Ye, Frank Attenello
Journal: Neurooncol Adv
Publication Date: 2022-08-19
Lead Sponsor: TVAX Biomedical
Intervention / Treatment: BIOLOGICAL: TVI-Brain-1, PROCEDURE: Standard of Care, RADIATION: Radiotherapy, DRUG: Temozolomide
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Temozolomide, PROCEDURE: Biospecimen Collection, DRUG: Selinexor
Lead Sponsor: Neonc Technologies, Inc.
Intervention / Treatment: DRUG: NEO100